NasdaqGM - Delayed Quote • USD
Summit Therapeutics Inc. (SMMT)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:08 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| Low Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| High Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| Year Ago EPS | -- | -- | -- | -0.24 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.06 | -0.06 | -0.24 | -0.29 |
| 7 Days Ago | -0.06 | -0.06 | -0.24 | -0.29 |
| 30 Days Ago | 0 | 0 | -0.4 | -0.15 |
| 60 Days Ago | 0 | 0 | -0.4 | -0.15 |
| 90 Days Ago | 0 | 0 | -0.4 | -0.15 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SMMT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.40% |
| Next Qtr. | -- | -- | -- | 10.90% |
| Current Year | -- | -- | -- | 4.50% |
| Next Year | -20.80% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Stifel: Buy | 3/26/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 11/18/2020 |
| Initiated | HC Wainwright & Co.: Buy | 3/19/2020 |
| Downgrade | Janney Montgomery Scott: Buy to Neutral | 6/28/2018 |
| Downgrade | SunTrust Robinson Humphrey: Buy to Hold | 6/27/2018 |
| Initiated | Janney Montgomery Scott: Buy | 5/2/2018 |
Related Tickers
ALZN Alzamend Neuro, Inc.
0.7195
-0.90%
MOR MorphoSys AG
18.04
-0.50%
BCDA BioCardia, Inc.
0.3766
+2.95%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
PROK ProKidney Corp.
2.1200
-21.77%
BHVN Biohaven Ltd.
38.97
+1.12%
VERA Vera Therapeutics, Inc.
39.65
+2.48%
APGE Apogee Therapeutics, Inc.
47.13
+2.77%
RNAC Cartesian Therapeutics, Inc.
21.03
+0.62%
ADAP Adaptimmune Therapeutics plc
1.0750
+1.42%